I employ an interactive, solution-focused approach. My therapeutic method involves providing support and practical feedback to help clients address personal life challenges effectively. I integrate ...
Ionis receives U.S. FDA Breakthrough Therapy designation for zilganersen for Alexander disease (AxD)
CARLSBAD, Calif.--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ...
Ionis receives U.S. FDA Breakthrough Therapy designation for zilganersen for Alexander disease (AxD)
– First and only investigational medicine for this rare, often fatal neurological condition – – On track to submit new drug application (NDA) in Q1 2026 – CARLSBAD, Calif.--(BUSINESS WIRE)-- Ionis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results